itraconazole brand
Selected indexed studies
- Antifungal Agents. (, 2012) [PMID:31643715]
- Aripiprazole Therapy and CYP2D6 Genotype. (, 2012) [PMID:28520375]
- Comparison of Compounded, Generic, and Innovator-Formulated Itraconazole in Dogs and Cats. (J Am Anim Hosp Assoc, 2018) [PMID:29757665]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Antifungal Agents. (2012) pubmed
- Aripiprazole Therapy and CYP2D6 Genotype. (2012) pubmed
- Comparison of Compounded, Generic, and Innovator-Formulated Itraconazole in Dogs and Cats. (2018) pubmed
- No evidence of resistance to itraconazole in a prospective real-world trial of dermatomycosis in India. (2023) pubmed
- Efficacy of generic forms of itraconazole capsule in treating subjects with chronic pulmonary aspergillosis. (2023) pubmed
- An office-based evaluation of various itraconazole brands. (2023) pubmed
- Generic Drug Shortage in Japan: GMP Noncompliance and Associated Quality Issues. (2023) pubmed
- Beads and Beyond: An Observational Study to Generate Real World Evidence on Various Brands of Itraconazole. (2022) pubmed
- Bioequivalence of orally administered generic, compounded, and innovator-formulated itraconazole in healthy dogs. (2014) pubmed
- Susceptibility and resistance of Sporothrix brasiliensis to branded and compounded itraconazole formulations. (2021) pubmed